Pfizer Shares Rise Amid Sangamo Partnership Termination
Pfizer shares slightly increased despite ending its collaboration with Sangamo. Explore what this means for investors and the future of biotech cooperation.
Pfizer shares saw a slight increase despite ending the collaboration with Sangamo.